The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index; 3 of the 56 sources its claims cite were checked for support.
Genetic variation in CCDC93 is associated with elevated central systolic blood pressure, impaired arterial relaxation, and mitochondrial dysfunction
Open accessAbstract
Genetic studies of blood pressure (BP) traits to date have been performed on conventional measures by brachial cuff sphygmomanometer for systolic BP (SBP) and diastolic BP, integrating several physiologic occurrences. Genetic associations with central SBP (cSBP) have not been well-studied. Genetic discovery studies of BP have been most often performed in European-ancestry samples. Here, we investigated genetic associations with cSBP in a Chinese population and functionally validated the impact of a novel associated coiled-coil domain containing 93 ( CCDC93 ) gene on BP regulation. An exome-wide association study (EWAS) was performed using a mixed linear model of non-invasive cSBP and peripheral BP traits in a Han Chinese population (N = 5,954) from Beijing, China genotyped with a customized Illumina ExomeChip array. We identified four SNP-trait associations with three SNPs, including two novel associations (rs2165468-SBP and rs33975708-cSBP). rs33975708 is a coding variant in the CCDC93 gene, c.535C>T, p.Arg179Cys (MAF = 0.15%), and was associated with increased cSBP (β = 29.3 mmHg, P = 1.23x10 -7 ). CRISPR/Cas9 genome editing was used to model the effect of Ccdc93 loss in mice. Homozygous Ccdc93 deletion was lethal prior to day 10.5 of embryonic development. Ccdc93 +/- heterozygous mice were viable and morphologically normal, with 1.3-fold lower aortic Ccdc93 protein expression ( P = 0.0041) and elevated SBP as compared to littermate Ccdc93 +/+ controls (110±8 mmHg vs 125±10 mmHg, P = 0.016). Wire myography of Ccdc93 +/- aortae showed impaired acetylcholine-induced relaxation and enhanced phenylephrine-induced contraction. RNA-Seq transcriptome analysis of Ccdc93 +/- mouse thoracic aortae identified significantly enriched pathways altered in fatty acid metabolism and mitochondrial metabolism. Plasma free fatty acid levels were elevated in Ccdc93 +/- mice (96±7mM vs 124±13mM, P = 0.0031) and aortic mitochondrial dysfunction was observed through aberrant Parkin and Nix protein expression. Together, our genetic and functional studies support a novel role of CCDC93 in the regulation of BP through its effects on vascular mitochondrial function and endothelial function.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
An exome-wide association study in Han Chinese identified rs33975708 in CCDC93 as associated with elevated central systolic blood pressure, and a Ccdc93 heterozygous mouse model recapitulated higher systolic BP with impaired arterial relaxation and mitochondrial dysfunction. The findings support a role for CCDC93 in BP regulation through vascular endothelial and mitochondrial mechanisms.
Key findings
- In the PUUMA EWAS (N = 5,954; 4,938 with cSBP), four SNP-trait associations reached genome-wide significance, including two novel associations: rs2165468 with pSBP and rs33975708 with cSBP. rs33975708 is a coding CCDC93 variant (c.535C>T, p.Arg179Cys; MAF = 0.15%) associated with increased cSBP (β = 29.3 mmHg, P = 1.23×10−7).
- Replication of rs33975708-cSBP was directionally consistent: visit 2 cSBP β = 23.63, P = 2.58×10−3; long-term averaged cSBP β = 24.63, P = 9.95×10−8; Ji cohort β = 11.18, P = 0.25; meta-analysis β = 24.82, P = 2.29×10−7. The risk allele was associated with lower CCDC93 expression in tibial artery in GTEx (P = 1.4×10−5).
- Ccdc93+/- mice were viable and had lower aortic Ccdc93 protein expression (1.3-fold lower, P = 0.0041) and higher SBP than littermate controls (125±10 vs 110±8 mmHg, P = 0.016). Homozygous Ccdc93 deletion was embryonic lethal prior to E10.5.
- Ccdc93+/- aortae showed impaired acetylcholine-induced relaxation (86% vs 68%, P = 0.029 at ACh 10−5 M) and enhanced phenylephrine-induced contraction (123% vs 198%, P = 0.015). RNA-Seq identified 368 upregulated and 131 downregulated transcripts, enriched in fatty acid and mitochondrial metabolism; plasma free fatty acids were elevated (124±13 vs 96±7 mM, P = 0.0031), with increased aortic Parkin and Nix.
Methods
- Discovery EWAS in the Han Chinese PUUMA cohort (N = 5,954; 86,148 SNPs after QC) used a custom Illumina ExomeChip and mixed linear models adjusted for age, age2, BMI, and sex, with Bonferroni significance P < 5.8×10−7. Replication used visit 2 and long-term averaged cSBP in PUUMA, the Ji cohort, and Peking University First and Third Hospital samples for pSBP.
- A CRISPR/Cas9-generated Ccdc93+/- mouse model was characterized with tail-cuff BP, wire myography, RNA-Seq of thoracic aortae, EC-TRAP, histology, Western blot, plasma free fatty acid/glucose assays, and body composition analysis.
- Human analyses included genetic risk scores for published BP GWAS, pleiotropy analyses with linear regression, and meta-analyses; mouse experiments used unpaired two-tailed t-tests with P < 0.05.
Limitations
- Stated: the study had a modest sample size compared with larger peripheral BP GWAS; replication was underpowered because of limited ancestry-matched cohorts with cSBP measurement and the rarity of rs33975708; a mouse model was therefore used for functional validation.
- Stated: GTEx eQTL data were largely from European ancestry individuals, limiting direct ancestry-matched interpretation.
- Evident from the text: the Ji cohort replication was small (N = 76; 9 risk-allele carriers) and not statistically significant; human FFA analysis in rs33975708 A carriers was underpowered (1.67-fold increase, P = 0.35); mouse experiments used small groups (e.g., N = 3–4 per genotype for BP and N = 3 per group for RNA-Seq).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 of 56 cited sources checked · 1 supported · 0 flagged · accuracy not yet measured
- Findingown data
Wire myography of Ccdc93+/- aortae showed impaired acetylcholine-induced relaxation.
“Wire myography of Ccdc93+/- aortae showed impaired acetylcholine-induced relaxation and enhanced phenylephrine-induced contraction.”
Quote in the paperSubstantial claim - Findingown data
rs2165468 on chromosome 10p15.2 between PITRM1 and KLF6 was associated with pSBP (risk allele A; risk allele frequency 0.46; β = 1.77; SE = 0.34; P = 1.55×10−7).
“rs2165468 located on chromosome 10p15.2 and between PITRM1 (dist = 301,072 bp from GRCh37 genome assembly) and KLF6, was associated with pSBP (risk allele: A; risk allele frequency: 0.46; β = 1.77; SE = 0.34; P = 1.55×10−7)”
Quote in the paperSubstantial claim - Findingown data
Ccdc93+/- mice have elevated systolic blood pressure compared to littermate Ccdc93+/+ controls (110±8 vs 125±10 mmHg, P = 0.016).
“elevated SBP as compared to littermate Ccdc93+/+ controls (110±8 mmHg vs 125±10 mmHg, P = 0.016).”
- Also stated in: § Mice deficient in Ccdc93 demonstrated higher SBP and impaired arterial relaxation · plain
“Baseline SBP was significantly higher in Ccdc93+/- mice measured at two time-points one week apart (week 1: 125.15±10.24 mmHg, week 2: 123.01±9.19 mmHg, Fig 2A) as compared to littermate Ccdc93+/+ mice (week 1: 110.31±8.17 mmHg, P = 0.016, week 2: 110.03±8.87 mmHg, P = 0.023).”
Quote in the paperSubstantial claim - Also stated in: § Mice deficient in Ccdc93 demonstrated higher SBP and impaired arterial relaxation · plain
- Findingown data
The associations of rs13149993 with pDBP and rs13149993 with pMAP reported in previous studies were replicated in the East-Asian population.
“The associations of rs13149993 with pDBP and rs13149993 with pMAP reported in previous studies [32] were replicated in our East-Asian population.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] TN Kelly, 2013, Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci, Hypertension source
- Findingown data
RNA-Seq of Ccdc93+/- mouse thoracic aortae identified significantly enriched pathways altered in fatty acid metabolism and mitochondrial metabolism.
“RNA-Seq transcriptome analysis of Ccdc93+/- mouse thoracic aortae identified significantly enriched pathways altered in fatty acid metabolism and mitochondrial metabolism.”
Quote in the paperSubstantial claim
- Findingown data
Homozygous Ccdc93 deletion in mice is lethal prior to embryonic day 10.5.
“Homozygous Ccdc93 deletion was lethal prior to day 10.5 of embryonic development.”
- Also stated in: § Generation and characteristics of Ccdc93 mutant mice and eQTL analysis · plain
“Ccdc93 null (Ccdc93-/-) mice were embryonic lethal and died prior to embryonic day E10.5 (S6 Fig), supporting that Ccdc93 is indispensable for embryonic development.”
Quote in the paperNot a substantial claim - Also stated in: § Generation and characteristics of Ccdc93 mutant mice and eQTL analysis · plain
- Findingown data
Plasma free fatty acid levels were elevated in Ccdc93+/- mice (96±7mM vs 124±13mM, P = 0.0031).
“Plasma free fatty acid levels were elevated in Ccdc93+/- mice (96±7mM vs 124±13mM, P = 0.0031) and aortic mitochondrial dysfunction was observed through aberrant Parkin and Nix protein expression.”
Quote in the paperSubstantial claim - Findingown data
Wire myography of Ccdc93+/- aortae showed enhanced phenylephrine-induced contraction.
“Wire myography of Ccdc93+/- aortae showed impaired acetylcholine-induced relaxation and enhanced phenylephrine-induced contraction.”
Quote in the paperSubstantial claim - Findingown data
Aortic mitochondrial dysfunction was observed in Ccdc93+/- mice through aberrant Parkin and Nix protein expression.
“Plasma free fatty acid levels were elevated in Ccdc93+/- mice (96±7mM vs 124±13mM, P = 0.0031) and aortic mitochondrial dysfunction was observed through aberrant Parkin and Nix protein expression.”
Quote in the paperSubstantial claim - Findingown data
rs33975708 was associated with increased central systolic blood pressure (cSBP) (β = 29.3 mmHg, P = 1.23x10-7).
“rs33975708 is a coding variant in the CCDC93 gene, c.535C>T, p.Arg179Cys (MAF = 0.15%), and was associated with increased cSBP (β = 29.3 mmHg, P = 1.23x10-7).”
- Also stated in: § PUUMA cohort discovery stage EWAS · plain
“rs33975708 located on chromosome 2q14.1 in CCDC93 was associated with cSBP (risk allele: A; risk allele frequency = 0.002; β = 29.31; SE = 5.53; P = 1.23×10−7).”
Quote in the paperSubstantial claim - Also stated in: § PUUMA cohort discovery stage EWAS · plain
- Findingown data
rs33975708 on chromosome 2q14.1 in CCDC93 was associated with cSBP (risk allele A; risk allele frequency = 0.002; β = 29.31; SE = 5.53; P = 1.23×10−7).
“rs33975708 located on chromosome 2q14.1 in CCDC93 was associated with cSBP (risk allele: A; risk allele frequency = 0.002; β = 29.31; SE = 5.53; P = 1.23×10−7).”
Quote in the paperSubstantial claim - Findingown data
rs13149993 on chromosome 4q21.21 within FGF5 was associated with pDBP (risk allele A; risk allele frequency 0.42; β 1.06; SE 0.21; P 3.16×10−7).
“rs13149993 on chromosome 4q21.21 locus within FGF5 was associated with pDBP (risk allele: A; risk allele frequency: 0.42; β: 1.06; SE: 0.21; P: 3.16×10−7)”
Quote in the paperNot a substantial claim - Findingown data
rs13149993 was associated with pMAP (risk allele A; risk allele frequency 0.42; β 1.24, SE 0.24; P 1.67×10−7).
“and pMAP (risk allele: A; risk allele frequency: 0.42; β: 1.24, SE: 0.24; P: 1.67×10−7).”
Quote in the paperNot a substantial claim - Findingown data
Aortic Ppar-α protein was significantly higher in Ccdc93+/- mice than in littermate controls (1.28-fold higher, P = 0.018).
“Aortic peroxisome proliferator-activated receptor-alpha (Ppar-α) was significantly higher in Ccdc93+/- mice as compared to littermate controls (1.28-fold higher, P = 0.018”
Quote in the paperNot a substantial claim - Findingown data
Immunohistochemistry demonstrated Ccdc93 protein expression in the endothelium of mesenteric artery of wild-type mouse.
“Immunohistochemistry showed Ccdc93 protein expression was enriched in the endothelium of mesenteric artery of Ccdc93+/+ wild-type mouse (129/Sv).”
Quote in the paperSubstantial claim - Findingown data
Differential expression analysis comparing Ccdc93+/- to Ccdc93+/+ littermate control aortae identified 368 significantly upregulated and 131 downregulated transcripts (FDR<0.1, log2FC>0.5).
“Differential expression analysis comparing Ccdc93+/- to Ccdc93+/+ littermate control aortae identified 368 significantly upregulated and 131 downregulated transcripts (FDR<0.1, log2FC>0.5, Fig 3B)”
Quote in the paperSubstantial claim - Findingown data
Meta-analysis of the two replication results for rs2165468 with pSBP showed a positive association with consistent effect direction (β = 2.3, SE = 1.04, P = 0.026).
“in the meta-analysis of the two replication results, a positive association with consistent effect direction was observed (β = 2.3, SE = 1.04, P = 0.026) (S2 Table).”
Quote in the paperSubstantial claim - Findingown data
Liver weight relative to body weight was mildly increased in Ccdc93+/- mice.
“Liver weight relative to body weight was examined since the liver contributes to FFA pools in tissues and plasma [42], and this was mildly increased in Ccdc93+/-mice”
Quote in the paperNot a substantial claim - Findingown data
In the Ji cohort, individuals carrying the rs33975708-A risk allele had mean cSBP 175.1 mmHg (s.d. 30.7) vs 162.5 mmHg (s.d. 26.2) in non-carriers (t-test P=0.19).
“individuals in the Ji cohort with the rs33975708-A CCDC93 risk allele had a mean cSBP of 175.1 mmHg (s.d. = 30.7 mmHg) whereas individuals who did not carry the risk allele had a mean cSBP of 162.5 mmHg (s.d. = 26.2 mmHg) with t-test P-value = 0.19.”
Quote in the paperNot a substantial claim - Findingown data
Aortic Parkin and Nix protein were significantly elevated in Ccdc93+/- mice.
“Aortic Parkin and Nix protein, both of which are markers of mitochondrial dysfunction were significantly elevated in Ccdc93+/- mice”
Quote in the paperSubstantial claim - Findingown data
Long-term averaged cSBP was associated with rs33975708 (β = 24.63, SE = 6.62, P = 9.95×10−8).
“LTA-cSBP was associated with rs33975708, with a stronger effect estimate and lower p-value (β = 24.63, SE = 6.62, P = 9.95×10−8) as compared to the initial discovered association result (S2 Table).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] SK Ganesh, 2014, Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations, Am J Hum Genet source
- Findingown data
Mitochondrial dysfunction was validated through examination of protein marker expression in Ccdc93+/- mice compared to controls.
“Mitochondrial dysfunction was validated through the examination of protein marker expression in Ccdc93+/- mice as compared to controls.”
Quote in the paperSubstantial claim - Findingown data
In Ccdc93+/- mouse aortae, Cyc1, Aldh5a1, and Aldh1a7 transcript expression were significantly higher than in Ccdc93+/+ controls.
“c1 (Cyc1), aldehyde dehydrogenase 5 family member A1 (Aldh5a1), and aldehyde dehydrogenase family 1, subfamily A7 (Aldh1a7) were significantly higher in Ccdc93+/- as compared to controls.”
Quote in the paperSubstantial claim - Findingown data
Mice with heterozygous loss of Ccdc93 demonstrated higher SBP than littermate control mice.
“mice with heterozygous loss of Ccdc93 indeed demonstrated higher SBP than littermate control mice.”
Quote in the paperSubstantial claim - Findingnone given
Ccdc93 expression was enriched in the vascular endothelium.
“Ccdc93 expression was enriched in the vascular endothelium”
Quote in the paperNot a substantial claim - Findingown data
Liver histology by H&E showed no histologically evident lesions to explain the increased liver weight in Ccdc93+/- mice.
“Analysis of liver histology by H&E showed no histologically evident lesions to explain the increased liver weight in Ccdc93+/- mice”
Quote in the paperNot a substantial claim - Findingown data
In the replication analysis, the association of rs33975708 with second-visit cSBP was significant (N=2897, β = 23.63, SE = 7.84, P = 2.58×10−3).
“The association with rs33975708 for subjects with both first-visit and second-visit measurements (N = 2897), utilizing only the second visit cSBP measurement was significant, with a similar effect size as the discovery stage association of rs33975708 and cSBP (β = 23.63, SE = 7.84, P = 2.58×10−3).”
Quote in the paperSubstantial claim - Findingown data
At E10.5, 5 fetoplacental units of total 56 were Ccdc93-/- (9%).
“5 fetoplacental units (FPUs) of total 56 were Ccdc93-/- (9%, S6A Fig).”
Quote in the paperNot a substantial claim - Findingown data
Circulating plasma free fatty acid levels were significantly higher in Ccdc93+/- mice than in Ccdc93+/+ littermate controls.
“Circulating plasma free fatty acids (FFA) levels but not total cholesterol was significantly higher in Ccdc93+/- mice as compared to littermate controls”
- Also stated in: § Arterial transcript expression studies to localize Ccdc93 expression and identify mechanisms of Ccdc93 deficiency · plain
“Plasma free fatty acid was significantly increased in Ccdc93+/- mice as compared to Ccdc93+/+ littermate controls.”
Quote in the paperSubstantial claim - Also stated in: § Arterial transcript expression studies to localize Ccdc93 expression and identify mechanisms of Ccdc93 deficiency · plain
- Findingown data
RNA-seq of thoracic aortae showed 368 significantly upregulated and 131 downregulated genes in Ccdc93+/- compared to Ccdc93+/+ mice.
“Volcano plot showing significantly upregulated genes (368) and downregulated genes (131) in thoracic aortae of Ccdc93+/- compared to Ccdc93+/+ mice.”
Quote in the paperSubstantial claim - Findingown data
Transcripts involved in the mitochondrial ROS cascade including Mdh2, Xdh, Cyc1, Aldh5a1, and Aldh1a7 were significantly higher in Ccdc93+/- aortae.
“Transcripts involved in the mitochondrial reactive oxygen species (ROS) cascade including malate dehydrogenase 2 (Mdh2), xanthine dehydrogenase (Xdh), cytochrome c1 (Cyc1), aldehyde dehydrogenase 5 family member A1 (Aldh5a1), and aldehyde dehydrogenase family 1, subfamily A7 (Aldh1a7) were significantly higher”
Quote in the paperSubstantial claim - Findingown data
rs33975708 was significantly associated with several blood pressure traits including pSBP and Ba-PWV in PUUMA.
“rs33975708 was significantly associated with several BP traits including pSBP and Ba-PWV. (Table 3 and S4 Fig).”
Quote in the paperSubstantial claim - Findingown data
Gene ontology and pathway analyses showed a strong enrichment of pathways of mitochondrial function including fatty acid metabolism, oxidoreductase pathway, mitochondrial fatty acid beta oxidation, and reactive oxygen species production.
“Gene ontology and pathway analyses showed a strong enrichment of pathways of mitochondrial function including fatty acid metabolism, oxidoreductase pathway, mitochondrial fatty acid beta oxidation, and reactive oxygen species production (Figs 3C–3H and S10C).”
Quote in the paperSubstantial claim - Findingown data
No sex-specific signals were identified in secondary analyses stratified by sex.
“secondary analyses were performed stratified by sex that identified no sex-specific signals (S11 Fig).”
Quote in the paperNot a substantial claim - Findingown data
Ccdc93-/- in homozygous form was embryonic lethal.
“Ccdc93-/- in its homozygous form was embryonic lethal”
Quote in the paperNot a substantial claim - Findingown data
rs33975708 demonstrated pleiotropic associations with peripheral BP traits, Ba-PWV and LDL cholesterol.
“This variant demonstrated pleiotropic associations with peripheral BP traits, Ba-PWV and LDL cholesterol”
Quote in the paperNot a substantial claim - Findingown data
Ppar-α expression was significantly higher in Ccdc93+/- mice at both transcript and protein levels.
“Peroxisome proliferator-activated receptors-α (Ppar-α) is a member of the superfamily of ligand-activated nuclear transcription factors and its expression was significantly higher in Ccdc93+/- mice, both at transcript- and protein-levels.”
Quote in the paperSubstantial claim - Findingown data
Heart rate was not different in Ccdc93+/- mice compared to Ccdc93+/+ littermate controls.
“Heart rate was similar in Ccdc93+/- and Ccdc93+/+ littermate control mice (Fig 2B).”
Quote in the paperNot a substantial claim - Findingown data
Fat mass and weights of gonadal and inguinal white adipose tissue and interscapular brown adipose tissue were not statistically different between Ccdc93+/- mice and Ccdc93+/+ littermate controls.
“Fat mass and weights of adipose tissues from three different anatomic locations (gonadal and inguinal white adipose tissue, and interscapular brown adipose tissue) were not statistically different between Ccdc93+/- mice compared to Ccdc93+/+ littermate controls”
Quote in the paperNot a substantial claim - Findingown data
Transcriptome analysis showed increased expression of ROS transcripts including Mdh2, Xdh, Cyc1, Aldh5a1, and Aldh1a7 in Ccdc93+/- mice.
“Transcriptome analysis defined mitochondrial dysfunction and expression of key reactive oxygen species (ROS) transcripts including Mdh2, Xdh, Cyc1, Aldh5a1, Aldh1a7 increased in Ccdc93+/- mice”
Quote in the paperSubstantial claim - Findingown data
A positive correlation of mouse FFA levels was observed in human samples.
“A positive correlation of mouse FFA levels was observed in our human samples.”
Quote in the paperNot a substantial claim - Findingown data
In Ccdc93+/- mouse aortae, Acaa2, Acad9, and Cyp2u1 transcript expression were higher than in controls.
“Acetyl-Coenzyme A acyltransferase 2 (Acaa2), Acyl coenzyme-A dehydrogenase 9 (Acad9) and cytochrome P450, family 2, subfamily u, polypeptide 1 (Cyp2u1) transcript expression were higher in Ccdc93+/-”
Quote in the paperSubstantial claim - Findingown data
Plasma glucose was similar in Ccdc93+/- heterozygous mice and Ccdc93+/+ littermate controls.
“Plasma glucose was similar in Ccdc93+/- heterozygous mice as compared to the littermate Ccdc93+/+ control mice”
Quote in the paperNot a substantial claim - Findingown data
EC-TRAP confirmed Ccdc93 transcript expression was enriched in endothelial cells of thoracic aortae and mesenteric arteries of C57BL/6 wild-type mice.
“Endothelial cell-specific translating ribosome affinity purification (EC-TRAP) confirmed that Ccdc93 transcript expression was indeed enriched in the endothelial cells (immunoprecipitated-hemagglutinin IP-HA fraction) of thoracic aortae and mesenteric arteries of C57BL/6 wild-type mice (N = 3–4 in each group).”
Quote in the paperSubstantial claim - Interpretationown data
The genetic and functional studies support a novel role of CCDC93 in the regulation of blood pressure through its effects on vascular mitochondrial function and endothelial function.
“Together, our genetic and functional studies support a novel role of CCDC93 in the regulation of BP through its effects on vascular mitochondrial function and endothelial function.”
Quote in the paperSubstantial claim - Premiseown data
Only rs33975708-cSBP exhibited a significant association with CCDC93 in tibial artery in GTEx v8.
“Only rs33975708-cSBP exhibited a significant association with CCDC93 in tibial artery in GTEx v8.”
Quote in the paperSubstantial claim - Premiseown data
After multiple test correction, rs33975708 was significantly associated with cis-eQTL gene CCDC93 in tibial artery (P = 1.4x10-5, normalized effect size = -0.2).
“After multiple test correction (Storey’s q value), we identified a significant association between rs33975708 and the cis-eQTL gene CCDC93, in tibial artery (P = 1.4x10-5, normalized effect size = -0.2, Fig 1D).”
Quote in the paperSubstantial claim - Interpretationown data
The SBP elevation in Ccdc93+/- mice confirms the direction of the discovered human genetic effect.
“SBP elevation was observed in Ccdc93+/- mice as compared to their Ccdc93+/+ littermate controls, confirming the direction of the discovered human genetic effect.”
Quote in the paperSubstantial claim- Rests on an assumption: The Ccdc93+/- heterozygous mouse is a valid model of the human CCDC93 rs33975708 loss-of-function state.
- Rests on an assumption: Mouse SBP findings can confirm the direction of the human genetic effect on SBP.
- Premisecitation
cSBP was superior to pSBP for the prediction of future cardiovascular events.
“cSBP was superior to pSBP for the prediction of future cardiovascular events [45].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] F Lamarche, 2018, Central and brachial blood pressures, statins, and low-density lipoprotein cholesterol: a mediation analysis, Hypertension source
- Interpretationown data
Ccdc93 is indispensable for embryonic development.
“supporting that Ccdc93 is indispensable for embryonic development.”
Quote in the paperNot a substantial claim - Interpretationown data
Mitochondrial-derived ROS production may mediate the observed hypertensive effects in Ccdc93+/- mice.
“suggest mitochondrial-derived ROS production may mediate the observed hypertensive effects”
Quote in the paperSubstantial claim - Study design and conductreasoning
Replication experiments were under-powered due to limited availability of ancestry-matched cohorts with cSBP measurement and the rarity of the discovered variant.
“Due to the limited availability of ancestry-matched cohorts with cSBP measurement and the rarity of the discovered variant, replication experiments were under-powered”
Quote in the paperSubstantial claim - Premiseown data
rs33975708 showed an expression QTL association with lower CCDC93 expression in tibial artery in GTEx (P = 0.000014).
“rs33975708 showed an expression QTL association with lower CCDC93 expression in tibial artery in the GTEx database (P = 0.000014, Fig 1D)”
Quote in the paperSubstantial claim - Study design and conductnone given
The study had a modest sample size, particularly compared to larger GWAS for peripheral BP traits.
“The limitations of this study include a modest sample size, particularly compared to larger GWAS that have been carried out for peripheral BP traits.”
Quote in the paperNot a substantial claim - Interpretationown data
The current study's findings suggest that fatty acid metabolism and mitochondrial dysfunction play key roles in regulating BP and vascular function in Ccdc93+/- mice.
“The current study’s findings suggest that fatty acid metabolism and mitochondrial dysfunction play key roles in regulating BP and vascular function in Ccdc93+/- mice.”
Quote in the paperSubstantial claim
- Probably not a substantial claim. 64
- It may state two separate claims as one. 56
Probably not a substantial claim.
Study design and conductcitationA mixed linear model considering kinship was performed using EMMAX, a statistical test for large-scale human or model organism association mapping that accounts for sample structure.
“A mixed linear model considering kinship was performed using the EMMAX program [84], which is a statistical test for large scale human or model organism association mapping accounting for the sample structure.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [84] HM Kang, 2010, Variance component model to account for sample structure in genome-wide association studies, Nat Genet source
The Discussion (page not provided) identifies EMMAX as an expedited mixed linear model that accounts for kinship and corrects sample structure in human GWASs. The paper demonstrates EMMAX on human datasets; it mentions similar approaches in animal models but does not establish EMMAX as a test for model-organism association mapping. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationXdh-derived ROS are proinflammatory in the vasculature as they increase vascular permeability and arteriolar tone and thus promote hypertension, cardiovascular diseases, and atherosclerosis.
“Xdh-derived ROS are proinflammatory in the vasculature as they increase vascular permeability and arteriolar tone [57] and thus promote hypertension, cardiovascular diseases, and atherosclerosis [58,59].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [57] H Cai, 2000, Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress, Circ Res source
The Xanthine Oxidase section (page not provided) links xanthine oxidase–derived superoxide to blood pressure in hypertensive rats and to early experimental atherosclerosis. The Abstract also links oxidant stress broadly to cardiovascular disease. But the paper distinguishes xanthine dehydrogenase from xanthine oxidase and does not establish the disease-promoting claim specifically for dehydrogenase-derived ROS. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [58] MG Battelli, 2014, Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress, Atherosclerosis source
- cites [59] SM Ghosh, 2013, Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential, Hypertension source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationParkin is an E3-ubiquitous ligase that accumulates on the outer membrane of damaged mitochondria, ubiquitinates mitochondrial outer membrane proteins, and activates mitochondria for autophagy and degradation in lysosomes.
“The protein Parkin is a E3-ubiquitous ligase that accumulates on the outer membrane of damaged mitochondria which ubiquitinates mitochondrial outer membrane proteins [65,66], and activates mitochondria for autophagy and degradation in lysosomes [67].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [65] P Ge, 2020, PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease., Mol Neurodegener. source
- cites [66] DJ Tyrrell, 2020, Aging Impairs Mitochondrial Function and Mitophagy and Elevates Interleukin 6 Within the Cerebral Vasculature., J Am Heart Assoc source
- cites [67] D Narendra, 2008, Parkin is recruited selectively to impaired mitochondria and promotes their autophagy, J Cell Biol source
It may state two separate claims as one.
Findingown dataA genetic risk score based on published SBP and DBP GWAS results was significantly associated with SBP (β = 0.68, SE = 0.06, P = 3.42×10−30) and DBP (β = 0.59, SE = 0.06, P = 2.5×10−24) in the study cohort.
“significant associations were identified with SBP (GRS-association of 611 SNPs β = 0.68, SE = 0.06, P = 3.42×10−30) and DBP (GRS-association of 734 SNPs β = 0.59, SE = 0.06, P = 2.5×10−24) in UKB with adjustment for age, age2, gender, BMI, and the top 10 PCs, and in ICBP (S1 Table).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] E Evangelou, 2018, Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits, Nat Genet source
It may state two separate claims as one.
Findingown datars33975708 is a coding variant in CCDC93 (c.535C>T, p.Arg179Cys) with MAF 0.15% in the study population.
“rs33975708 is a coding variant in the CCDC93 gene, c.535C>T, p.Arg179Cys (MAF = 0.15%), and was associated with increased cSBP (β = 29.3 mmHg, P = 1.23x10-7).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataAn exome-wide association study in a Han Chinese population identified four SNP-trait associations with three SNPs, including two novel associations (rs2165468-SBP and rs33975708-cSBP).
“We identified four SNP-trait associations with three SNPs, including two novel associations (rs2165468-SBP and rs33975708-cSBP).”
- Also stated in: § PUUMA cohort discovery stage EWAS · plain
“We identified four locus-trait combinations that reached the Bonferroni corrected genome wide significance threshold of P-value<5.8 × 10−7 in the discovery analysis, including 2 novel SNP-trait associations and 2 previously reported associations (Table 2).”
Quote in the paperSubstantial claim- Also stated in: § PUUMA cohort discovery stage EWAS · plain
It may state two separate claims as one.
Findingown dataHuman CCDC93 rs33975708 A carriers displayed higher FFA levels (1.67-fold increase, P = 0.35), which was not statistically significant in this underpowered analysis.
“human CCDC93 rs33975708 A carriers displayed higher FFA levels (1.67-fold increase, P = 0.35, S4 Table) that was not statistically significant in this underpowered analysis”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataCcdc93+/- mice demonstrated endothelial dysfunction, evidenced by impaired acetylcholine mediated relaxation, and enhanced arterial contractility.
“Ccdc93+/- mice demonstrated endothelial dysfunction, evidenced by impaired acetylcholine mediated relaxation, as well as enhanced arterial contractility.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataFPUs of Ccdc93+/- heterozygote contained developing embryos that appeared viable and had no evidence of necrosis, inflammation, or hemorrhage.
“FPUs of Ccdc93+/- heterozygote contained developing embryos that appeared viable and had no evidence of necrosis, inflammation, or hemorrhage (S6B Fig).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Findingown dataCcdc93+/- heterozygous mice displayed normal aortic histology on H&E and picrosirius red staining and normal peripheral blood counts.
“Ccdc93+/- heterozygous mice displayed normal aortic histology on H&E and picrosirius red staining (S8 Fig) and normal peripheral blood counts (S3 Table).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Findingown dataAortic Lrp1 protein expression was higher in Ccdc93+/- mice but did not reach statistical significance (1.17-fold higher, P = 0.083).
“low-density lipoprotein receptor-related protein (Lrp1) protein expression was higher but did not reach statistical significance (1.17-fold higher, P = 0.083”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataThe study replicated previously reported associations with BP traits and identified 2 novel associations, including the association of cSBP with rs33975708, a nonsynonymous variant in CCDC93 (c.535C>T, p.Arg179Cys).
“We replicated previously reported associations with BP traits, and identified 2 novel associations, including the association of cSBP with rs33975708, a nonsynonymous variant in CCDC93 (c.535C>T, p.Arg179Cys).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataNeither rs2165468-pSBP nor rs13149993-pDBP/pMAP identified any eQTL associations in GTEx v8 or other eQTL databases.
“Neither the specific SNPs nor any proxy SNP, when available, identified any eQTL associations for the additional variants, rs2165468-pSBP and rs13149993-pDBP/pMAP, using the updated GTEx v8 portal and other eQTL databases (such as the Human Genetic Variation Database).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataCcdc93+/- mice have a 21-nucleotide deletion in a region spanning intron 6/exon 7 and significantly reduced aortic Ccdc93 mRNA transcript and protein expression.
“Ccdc93 heterozygous (Ccdc93+/-) mice have a 21-nucleotide deletion in a region spanning intron 6/exon 7 (2 nucleotides in intron 6 and 19 nucleotides in exon 7, S5 Fig), and significantly reduced aortic Ccdc93 mRNA transcript and protein expression (Fig 2C–2E).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
FindingcitationMeta-analysis of discovery and Ji County data showed consistent directions of effect: β = 24.82, SE = 4.80, P = 2.29x10-7 by inverse-variance-weighted method, and P = 7.03x10-8 by weighted sum of Z-scores.
“Meta-analysis of discovery stage and Ji County data showed consistent directions of effect: β = 24.82, SE = 4.80, P = 2.29x10-7 utilizing inverse-variance-weighted method, and P = 7.03x10-8 by employing a weighted sum of Z-scores method [35].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] CH Lee, 2016, Comparison of Two Meta-Analysis Methods: Inverse-Variance-Weighted Average and Weighted Sum of Z-Scores, Genomics Inform source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataHeart weight, kidney weight, and spleen weight normalized over body weight were not significantly different in Ccdc93+/- compared to littermate controls.
“Heart weight, kidney weight and spleen weight normalized over body weight were not significantly different in Ccdc93+/- as compared to littermate controls (S7A–S7C Fig).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataHistological analysis at E10.5 of a single uterine horn revealed 2 resorption sites and 6 healthy FPUs.
“Histological analysis at E10.5 of a single uterine horn revealed 2 resorption sites and 6 healthy FPUs.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataReduced aortic Ccdc93 transcript expression was observed in Ccdc93+/- mice, consistent with qPCR data.
“with reduced aortic Ccdc93 transcript expression observed as expected in Ccdc93+/- mice, consistent with qPCR data (S10B Fig).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataTotal plasma cholesterol was not different between Ccdc93+/- and Ccdc93+/+ mice.
“Total plasma cholesterol was not different between the genotypes.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataIn the Ji cohort (N=76), the association of rs33975708 with cSBP was not statistically significant (β = 11.18, SE = 9.64, P = 0.25), but the effect direction was consistent with discovery.
“the association result was not statistically significant, but the effect direction was consistent with the discovery stage result (β = 11.18, SE = 9.64, P = 0.25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] C Zhan, 2016, Prevalence and Risk Factors of Carotid Plaque Among Middle-aged and Elderly Adults in Rural Tianjin, China., Sci Rep. source
It may state two separate claims as one.
Findingown dataPhenylephrine-induced contractile responses of Ccdc93+/- aorta were significantly higher starting at 10−6 M (P = 0.048) and maximal PE response at 10−5 M was 123% vs 198% (P = 0.015).
“Phenylephrine (PE)-induced contractile responses of Ccdc93+/- aorta to a high concentration of PE starting at 10−6 M was significantly higher in Ccdc93+/- when compared with Ccdc93+/+ littermate controls (P = 0.048) and remained highly contractile at all increasing PE doses, as compared to Ccdc93+/+ controls (maximal PE response at 10−5 M was 123% vs 198% normalized to maximal response to high KCl”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn Ccdc93+/- heterozygous mice, arterial Ccdc93 transcript expression was reduced approximately 50% and protein expression was reduced by 22%.
“In Ccdc93+/- heterozygous mice, arterial Ccdc93 transcript expression was reduced approximately 50% as expected, while protein expression was reduced by 22%”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataDescending thoracic aortic rings of Ccdc93+/- showed impaired acetylcholine-induced relaxation starting at ACh dose 10−7 M (P = 0.043) and remained impaired up to maximal ACh response (86% vs 68%, P = 0.029 at ACh 10−5 M).
“Descending thoracic aortic rings of Ccdc93+/- showed impaired acetylcholine (ACh)-induced relaxation starting at ACh dose 10−7 M (P = 0.043) and relaxation remained impaired for all increasing ACh doses tested up to a maximal ACh response, corresponding to 86% vs 68% (Ccdc93+/+ vs Ccdc93+/-, P = 0.029 at Ach 10−5 M, Fig 2F).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataIn an association study of exome-wide variants and BP traits in 5,954 Han Chinese individuals, 4 trait-locus associations with 4 BP traits were identified, including traditionally measured BP traits and cSBP.
“In an association study of exome-wide variants and BP traits in 5,954 Han Chinese individuals, we identified 4 trait-locus associations with 4 BP traits, including traditionally measured BP traits and cSBP”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataThe association of rs2165468 with pSBP was replicated in 565 participants from Peking University First Hospital (β = 2.45, SE = 1.15, P = 0.034), but not in 127 participants from Third Hospital (β = 1.7, SE = 2.38, P = 0.48).
“This association was replicated in 565 participants from Peking University First Hospital (β = 2.45, SE = 1.15, P = 0.034), but not replicated in 127 participants from third hospital (β = 1.7, SE = 2.38, P = 0.48), although under-powered analyses”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataResorption sites of Ccdc93-/- homozygous FPUs contained hemorrhage and necrotic debris accompanied by neutrophilic and lymphocytic inflammation within and around chorioallantoic membranes on the fetal side, with no embryos or embryonic tissues present.
“Resorption sites of Ccdc93-/- homozygous FPUs contained hemorrhage and necrotic debris accompanied by neutrophilic and lymphocytic inflammation within and around chorioallantoic membranes on the fetal side. There were no embryos or embryonic tissues present (S6C Fig)”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataUnbiased transcriptomic analysis demonstrated mitochondrial dysfunction in Ccdc93+/- mice, validated by elevated expression of Parkin and Nix.
“Unbiased transcriptomic analysis demonstrated mitochondrial dysfunction, an effect that was validated in the elevated expression of Parkin and Nix, markers of mitochondrial dysfunction.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataHuman CCDC93 rs33975708 A carriers showed similar blood glucose levels as non-carriers.
“CCDC93 rs33975708 A carriers showed similar blood glucose levels as compared to non-carriers (S4 Table)”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataTotal body weight and lean mass were higher in Ccdc93+/- heterozygous mice compared to littermate controls.
“Total body weight, and lean mass measured by echo magnetic resonance imaging (Echo MRI) were higher in Ccdc93+/- heterozygous mice as compared to the littermate controls (S12A Fig).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataUsing GRS, the complex genetic architecture of BP regulation in the cohort was aligned with that of previously reported BP GWAS.
“although using GRS, the complex genetic architecture of BP regulation in our cohort was aligned with that of previously reported BP GWAS.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataEndothelium-independent relaxation induced by sodium nitroprusside was impaired in Ccdc93+/- aortic rings at 3.16×10−7 M (P = 0.013), although to an overall milder degree than ACh-induced relaxation.
“Endothelium-independent relaxation induced by sodium nitroprusside was impaired in Ccdc93+/- aortic rings as compared to Ccdc93+/+ control aortic rings at 3.16×10−7 M sodium nitroprusside (P = 0.013, Fig 2G), although to an overall milder degree as compared to ACh-induced arterial relaxation.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataAfter QC, 5,954 samples and 86,148 SNPs were retained in the BP EWAS.
“Finally, 5,954 samples (2,185 males, 3,768 females) and 86,148 SNPs were retained after the QC in this BP EWAS.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationCentral systolic blood pressure is heritable with estimated heritability 0.18 in a twin study.
“cSBP is heritable, with estimated heritability 0.18 in a twin study [27];”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] H Snieder, 2000, Heritability of central systolic pressure augmentation: a twin study, Hypertension source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationConventionally measured systolic and diastolic blood pressure have estimated heritability 0.17-0.52.
“conventionally measured SBP and diastolic BP (DBP) has estimated heritability 0.17–0.52 [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] G Kolifarhood, 2019, Heritability of blood pressure traits in diverse populations: a systematic review and meta-analysis, J Hum Hypertens source
Probably not a substantial claim. It may state two separate claims as one.
PremisecitationMost blood pressure GWAS studies have been conducted in European ancestry samples, and relatively fewer in East Asian samples.
“Furthermore, most BP GWAS studies have been conducted in European ancestry samples, and relatively fewer have been conducted in East Asian samples [31].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] A Giri, 2019, Trans-ethnic association study of blood pressure determinants in over 750,000 individuals, Nat Genet source
It may state two separate claims as one.
PremisecitationDespite numerous GWAS of peripheral blood pressure, few studies have focused on genetic associations with central blood pressure.
“Despite numerous GWAS of peripheral BP, few studies have focused on genetic associations with central BP [29,30].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] RS Patel, 2012, A genetic risk variant for myocardial infarction on chromosome 6p24 is associated with impaired central hemodynamic indexes, Am J Hypertens source
- cites [30] M Cecelja, 2020, Genetic aetiology of blood pressure relates to aortic stiffness with bi-directional causality: evidence from heritability, blood pressure polymorphisms, and Mendelian randomization, Eur Heart J source
Probably not a substantial claim. It may state two separate claims as one.
PremisecitationCentral systolic blood pressure responds differently to certain blood-pressure-lowering drugs and may be more closely correlated with future cardiovascular events than peripheral blood pressure measured at the brachial artery.
“cSBP responds differently to certain BP-lowering drugs [17] and cSBP may be more closely correlated with future cardiovascular events as compared to peripheral BP measured at the brachial artery [18,19]”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [17] B Williams, 2006, Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study., Circulation source
- cites [18] MJ Roman, 2007, Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study, Hypertension source
- cites [19] R Pini, 2008, Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study, J Am Coll Cardiol source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductown dataThe EWAS used mixed linear models adjusted for age, age2, BMI, and sex, with λGC values ranging from 0.997 to 1.008.
“We conducted an EWAS for each BP trait, using mixed linear models, adjusted for age, age2, BMI, and sex, with resulting λGC values ranging from 0.997 to 1.008.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisenone givenThe cSBP-associated variant rs33975708 has an overall MAF in the 1000 genomes reference of 4.07%, with the lowest in East Asians (0.00%) and the highest in Europeans (8.55%).
“The cSBP-associated variant, rs33975708, has an overall MAF in the 1000 genomes reference of 4.07% but varies between populations, with the lowest in East Asians (0.00%) and the highest in Europeans (8.55%).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Premisenone givenIn ExAC, the frequency of rs33975708 was 0.2% in individuals of East Asian ancestry and 7.43% in European-ancestry individuals.
“in the Exome Aggregation Consortium (ExAC) database, the frequency of this variant was 0.2% in individuals of East Asian ancestry and 7.43% in European-ancestry individuals.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataConcordant endothelial-dependent and endothelial-independent relaxation impairment in Ccdc93+/- mice, along with increased contractile responses, suggests both endothelial and vascular smooth muscle defects in arterial function resulting from Ccdc93 deficiency.
“Concordant endothelial-dependent and endothelial-independent relaxation impairment in Ccdc93+/- heterozygous mice, along with increased contractile responses to vasoconstrictive challenges, suggested both endothelial and vascular smooth muscle defects in arterial function that result from Ccdc93 deficiency.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAcaa2, Acad9, and Cyp2u1 function in fatty acid beta-oxidation and lipid metabolism, and increased activity is associated with alteration of mitochondrial architecture, bioenergetics and oxidative stress.
“their functions are reported in fatty acid beta-oxidation and lipid metabolism, with increased activity associated with alteration of mitochondrial architecture, bioenergetics and oxidative stress [38–41].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [38] LF Shen, 2017, Role of S-Palmitoylation by ZDHHC13 in Mitochondrial function and Metabolism in Liver., Sci Rep source
- cites [39] DN Kwon, 2015, Oxidative stress and ROS metabolism via down-regulation of sirtuin 3 expression in Cmah-null mice affect hearing loss., Aging (Albany NY). source
- cites [40] C Tesson, 2012, Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia, Am J Hum Genet source
- cites [41] J Nouws, 2010, Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I, Cell Metab source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationXdh is a source of superoxide ion, hydrogen peroxide, and nitric oxide, which can function as second messengers in various downstream vascular pathways.
“Xdh is a source of superoxide ion, hydrogen peroxide, and nitric oxide, which can function as second messengers in various downstream vascular pathways [56].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] MG Battelli, 2016, Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects., Oxid Med Cell Longev source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAntihypertensive agents reduced pSBP more than cSBP (WMD 2.52 mmHg, 95% CI 1.35 to 3.69) and β-blockers posed a significantly greater reduction in pSBP compared to cSBP (WMD 5.19 mmHg, 95% CI 3.21 to 7.18).
“a meta-analysis showed antihypertensive agents reduced pSBP more than cSBP (weighted mean difference [WMD] 2.52 mmHg, 95% CI 1.35 to 3.69) and β-Blockers posed a significantly greater reduction in pSBP as compared to cSBP (WMD 5.19 mmHg, 95% CI 3.21 to 7.18) [26].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] TJ McGaughey, 2016, Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis, Am J Hypertens source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAbsence of COMMD9 resulted in reduced Notch-dependent signaling, and deletion of Commd9 led to embryonic lethality in mice due to abnormal cardiovascular development.
“Absence of COMMD9 resulted in reduced Notch-dependent signaling, and deletion of Commd9 led to embryonic lethality in mice due to abnormal cardiovascular development [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] H Li, 2015, Endosomal sorting of Notch receptors through COMMD9-dependent pathways modulates Notch signaling, J Cell Biol source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationCyc1 and Aldh5a1, Aldh1a7 are elevated under oxidative stress and function as ROS scavenger and detoxification of highly reactive aldehydes, respectively.
“Cyc1 and Aldh5a1, Aldh1a7 are elevated under oxidative stress and function as ROS scavenger and detoxification of highly reactive aldehydes, respectively [36,37].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] A Atlante, 2000, Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death., J Biol Chem source
- cites [37] S Singh, 2013, Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress, Free Radic Biol Med source
It may state two separate claims as one.
Interpretationown dataGeneration and characterization of a novel transgenic mouse model deficient in Ccdc93 identified a similar phenotype and prioritized vascular mechanisms of BP regulation by Ccdc93 for further study.
“we undertook the generation and characterization of a novel transgenic mouse model deficiency in Ccdc93, which identified a similar phenotype and prioritized vascular mechanisms of BP regulation by Ccdc93 for further study.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
PremisecitationcSBP is associated with future cardiovascular events, and associations independent of pSBP have been defined.
“cSBP is associated with future cardiovascular events, and associations independent of pSBP have been defined [19,23,24,44].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [19] R Pini, 2008, Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study, J Am Coll Cardiol source
- cites [23] HM Cheng, 2013, Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks, J Am Coll Cardiol source
- cites [24] KL Wang, 2009, Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?, J Hypertens source
- cites [44] Y Dong, 2020, Central rather than brachial pressures are stronger predictors of cardiovascular outcomes: a longitudinal prospective study in a Chinese population., J Clin Hypertens (Greenwich). source
It may state two separate claims as one.
Premiseown dataAll 92 proxy eSNPs showed the same effect as rs33975708 and CCDC93, with the minor allele linked to reduced CCDC93 expression.
“All 92 proxy eSNPs showed the same effect as rs33975708 and CCDC93, with the minor allele linked to reduced CCDC93 expression, indirectly supporting our study’s signals.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationMdh2 is the final enzyme in the mitochondrial tricarboxylic acid cycle and its activity is associated with increased oxidative stress in the brain of Alzheimer disease.
“Mdh2 is the final enzyme in the mitochondrial tricarboxylic acid cycle and its activity is associated with increased oxidative stress in the brain of Alzheimer disease [55].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] P Bubber, 2005, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann Neurol source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationRecycling to the cell surface of Notch is dependent on the CCC complex.
“The recycling to the cell surface of Notch is dependent on the CCC complex [46,47].”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationIn a previous genetic study of individuals of European ancestry, CCDC93 rs17512204 was associated with lower LDL-C levels, lower cardiovascular mortality, and lower risk of myocardial infarction.
“In a previous genetic study of individuals of European ancestry, CCDC93 (rs17512204; C>T, p.Pro228Leu) was associated with lower LDL-C levels, lower cardiovascular mortality, and lower risk of myocardial infarction [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] A Rimbert, 2020, A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor, Eur Heart J source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationBoth CCDC93 and the CCC complex mediate endosomal sorting of the low-density lipoprotein receptor (LDLR).
“Both CCDC93 and the CCC complex mediate endosomal sorting of the low-density lipoprotein receptor (LDLR) [43,48,49].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [43] A Rimbert, 2020, A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor, Eur Heart J source
- cites [48] A Fedoseienko, 2018, The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking, Circ Res source
- cites [49] P Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL., Nat Commun source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationAdditional CCDC93 variants have been associated with venous thromboembolism, triglyceride levels, and total cholesterol levels.
“Additional CCDC93 variants have been associated with venous thromboembolism, triglyceride levels, and total cholesterol levels [50–52].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [50] N Sinnott-Armstrong, 2021, Genetics of 35 blood and urine biomarkers in the UK Biobank, Nat Genet source
- cites [51] H Deguchi, 2020, Novel exomic rare variants associated with venous thrombosis, Br J Haematol source
- cites [52] D Klarin, 2018, Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program, Nat Genet source
It may state two separate claims as one.
Interpretationown dataCcdc93-/- embryos either did not develop or died very early in gestation.
“suggesting that Ccdc93-/- embryos either did not develop or died very early in gestation.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Premisenone givenCCDC93 gene encodes a protein that is part of the CCC protein complex comprised of COMMD, CCDC22, and CCDC93.
“The coiled-coil domain containing 93 (CCDC93) gene encodes for a protein that is part of the “CCC” protein complex comprised of COMMD, CCDC22, and CCDC93.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Premiseown dataUsing GTEx v8, 275 eSNPs for CCDC93 in aorta and 270 eSNPs in tibial artery were identified; 92 eSNPs were in LD with rs33975708 (R2>0.2, +/-500Kb).
“Using GTEx v8 data, we identified 275 expression-associated SNPs (eSNPs) for CCDC93 in the aorta and 270 eSNPs in the tibial artery. Of these, 92 eSNPs were in linkage disequilibrium (LD) with rs33975708 (R2>0.2, +/- 500Kb) as per 1000G CEU population.”
Quote in the paperSubstantial claimProbably not a substantial claim.
Study design and conductcitationSBP measurement in mice was performed by non-invasive tail-cuff plethysmography as previously described.
“Male and female Ccdc93+/- (129/Sv) mice and their littermate controls at 12–16 weeks of age underwent SBP measurement by non-invasive tail-cuff plethysmography (BP-2000, Visitech Systems, NC) as previously described [74].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] N Kumar, 2018, Thymosin beta4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension, Hypertension source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationNix plays a critical role in Parkin-mediated mitochondrial autophagy by controlling the mitochondrial translocation of Parkin.
“Nix also plays a critical role in Parkin-mediated mitochondrial autophagy by controlling the mitochondrial translocation of Parkin [69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] WX Ding, 2010, Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming, J Biol Chem source
Probably not a substantial claim.
Study design and conductown dataTwo novel identified SNPs with P < 5.8 × 10−7 (0.05/86,148) were re-examined in the replication stage.
“two novel identified SNPs with P <5.8 × 10−7 (0.05/86,148) were re-examined in replication stage.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationElevated plasma FFA levels have been positively associated with SBP in nondiabetic subjects in a cross-sectional study.
“elevated plasma FFA levels have been positively associated with SBP in nondiabetic subjects in a cross-sectional study [62].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] M Carlsson, 2000, High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease, Arterioscler Thromb Vasc Biol source
Probably not a substantial claim.
Study design and conductown dataAssociations of novel BP-related SNPs with coronary artery disease risk factors were tested using multivariate linear regression with models adjusting for sex and age.
“Associations of novel BP-related SNPs with risk factors of coronary artery disease (including blood lipids, BP traits, pulse wave velocity, and body mass index) were tested using multivariate linear regression, with models adjusting for sex and age, using R program.”
Quote in the paperSubstantial claimProbably not a substantial claim.
Study design and conductnone givenP < 0.05 was defined as statistically significant.
“P<0.05 was defined to be statistically significant.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationThe promoters of medium-chain acyl-CoA dehydrogenase and mitochondrial HMG-CoA synthase are Ppar-α responsive.
“The promoters of medium-chain acyl-CoA dehydrogenase and mitochondrial HMG-CoA synthase are Ppar-α responsive [60].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] B. Grygiel-Gorniak, 2014, Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications—a review, Nutr J source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationPPAR agonists are involved in the production of reactive oxygen species.
“PPAR agonists are also involved in the production of reactive oxygen species [61].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] E Teissier, 2004, Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties, Circ Res source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Premisenone givenPpar-α has been implicated in the regulation of genes involved in mitochondrial fatty acid β-oxidation.
“Ppar-α has been implicated in the regulation of genes involved in mitochondrial fatty acid β-oxidation.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductnone givenAll animal procedures were approved by University of Michigan IACUC, and mice were housed and cared for in accordance with the Guide for the Care and Use of Laboratory Animals.
“All animal procedures were approved by University of Michigan Institutional Animal Care and Use Committee (IACUC), and mice were housed and cared for in accordance with the Guide for the Care and Use of Laboratory Animals.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationAlterations in mitochondrial function and ROS production have been associated with endothelial dysfunction, development of hypertension, and cardiac hypertrophy.
“Evidence suggests that alterations in mitochondrial function and ROS production have been associated with endothelial dysfunction, development of hypertension, and cardiac hypertrophy [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] V Lahera, 2017, Role of Mitochondrial Dysfunction in Hypertension and Obesity., Curr Hypertens Rep source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenThe housekeeping gene product Gapdh served as a loading control.
“The housekeeping gene product Gapdh (1:10,000, # 97166, CST) served as a loading control.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataThe correlation r2 of allele frequencies between PUUMA Chinese samples and 1000 Genomes East Asian samples was 0.98.
“The correlation r2 of the allele frequencies between PUUMA Chinese samples and 1000 Genomes East Asian samples was 0.98.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataThe discovery stage tested 5,954 samples and 86,148 SNPs.
“5,954 samples and 86,148 SNPs were tested in the discovery stage”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenPhoto processing was confined to global adjustment of image size, white balance, brightness, or contrast that did not materially alter the interpretation of the image.
“Photo processing was confined to global adjustment of image size, white balance, brightness, or contrast that did not materially alter the interpretation of the image.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductnone givenStudy protocols were approved by the IRB of Peking University First Hospital and Peking University Health Science center, and by the University of Michigan IRB; written informed consent was collected from all subjects.
“Study protocols were approved by the Institutional Review Board (IRB) of Peking University First Hospital (IRB2014[816]) and Peking University Health Science center (IRB00001052-11086), and the study was approved by the University of Michigan IRB (HUM00074756). Written informed consent was collected from all subjects.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Study design and conductcitationVascular reactivity was assessed by wire myography as previously described.
“Vascular reactivity assessed by wire myography was performed as previously described [83].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] MD Stevenson, 2023, Reactivity of renal and mesenteric resistance vessels to angiotensin II is mediated by NOXA1/NOX1 and superoxide signaling, Am J Physiol Renal Physiol source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductown dataRNA-Seq analysis used DESeq2 and a significant threshold of FDR < 0.1.
“The significant threshold was defined as false discovery rate (FDR) < 0.1.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenCcdc93+/- mice were mated with C57BL/6 and 129/Sv mice for at least 10 generations to confirm germline transmission.
“Ccdc93+/- mice were mated with C57BL/6 mice and 129/Sv mice (Taconic Biosciences, NY, USA) for at least 10 generation to confirm germline transmission.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Study design and conductnone givenVariants that achieved a P-value less than 5×10−8 from GWAS of the same trait were selected and LD-pruned (R2 > 0.2 in a 500 Kb window).
“Variants that achieved a P-value less than 5×10−8 from GWAS of the same trait were selected and LD-pruned (R2>0.2 in a 500Kb window).”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductown dataGenotyping of Ccdc93+/- mice was performed by PCR and confirmed by Sanger sequencing.
“Genotyping of Ccdc93+/- mice was performed by PCR amplifying the region using forward (5’GGAAGGGTGGGAGCGAGGAG3’) and reverse primer (5’ GTTGGCTTGCTTGCTTCTTTCTTTC 3’) and confirmed by sanger sequencing (Genewiz, NJ), S5 Fig.”
Quote in the paperNot a substantial claimProbably not a substantial claim. It may state two separate claims as one.
Study design and conductnone givenGenotyping QC excluded variants with low cluster score, Hardy-Weinberg equilibrium deviations P < 0.0001 and call rate < 99%; variants with a minor allele count larger than 3 were included.
“Variants with low cluster score, Hardy-Weinberg equilibrium deviations P < 0.0001 and call rate < 99% were excluded. Variants with a minor allele count larger than 3 were included.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationNix is a mitochondrial protein and a member of the Bcl-2 family of apoptotic regulators and is implicated in the pathogenesis of cancer and heart disease by regulating mitophagy and cell death.
“Nix is a mitochondrial protein and a member of the Bcl-2 family of apoptotic regulators and is implicated in the pathogenesis of cancer and heart disease by regulating mitophagy and cell death [68].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] J Zhang, 2009, Role of BNIP3 and NIX in cell death, autophagy, and mitophagy, Cell Death Differ source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductcitationEC-TRAP was performed as previously described.
“EC-TRAP was performed as we have previously described [75].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] ACA Cleuren, 2019, The in vivo endothelial cell translatome is highly heterogeneous across vascular beds, Proc Natl Acad Sci U S A source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenλGC was evaluated for evidence of population stratification.
“λGC was evaluated for evidence of population stratification.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Study design and conductcitationNoninvasive cSBP measurements were performed using radial artery tonometry with an Omron HEM-9000AI device, as described and validated previously.
“Noninvasive cSBP measurements were performed in a seated position using radial artery tonometry with an Omron HEM-9000AI device, as we have described and validated previously [22].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22] F Fan, 2016, Noninvasive Central Systolic Blood Pressure Is More Strongly Related to Kidney Function Decline Than Peripheral Systolic Blood Pressure in a Chinese Community-Based Population, Hypertension source
Probably not a substantial claim.
PremisecitationA published BP GWAS including more than one million people was used to construct a BP weighted genetic risk score, with SNPs weighted by BP coefficients from that GWAS's discovery results.
“A published BP GWAS finding that included more than one million people was used to construct BP weighted genetic risk score (GRS), where SNPs were weighted according to BP coefficients from the GWAS discovery results(5).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] E Evangelou, 2018, Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits, Nat Genet source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenSlides were evaluated by a board-certified veterinary pathologist.
“Slides were evaluated by a board-certified veterinary pathologist using a BX45 Olympus light microscope.”
Quote in the paperNot a substantial claimProbably not a substantial claim. It may state two separate claims as one.
Study design and conductown dataSample QC excluded duplicates based on IBD analysis, gender mismatched samples, and samples with missing phenotypes; all samples had missing call rate < 1%; none failed inbreeding coefficient check.
“we excluded duplicates based on whole genome genotyping data IBD (Identical by descent) analysis, gender miss-matched samples, and samples with missing phenotypes. All samples had missing call rate < 1%. None of them failed QC in inbreeding coefficient check.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataThe GTX package in R was applied to test the association between PRS of known BP and the study's BP analysis using GWAS summary statistics adjusted for age, age2, sex, BMI, and principal components.
“The GTX package (https://www.rdocumentation.org/packages/gtx/versions/0.0.8) in R was applied to test the association between PRS of known BP and our BP analysis using GWAS summary statistics adjusted for age, age2, sex, BMI, and principal components (PCs).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
PremisecitationExperimental FFA elevation by intralipid infusion in non-obese women resulted in impaired capillary recruitment and acetylcholine-induced vasodilation in the skin microvasculature, as well as increased SBP.
“Experimental FFA elevation achieved by intralipid infusion in non-obese women resulted in impaired capillary recruitment and acetylcholine-induced vasodilation in the skin microvasculature, as well as increased SBP [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] RT de Jongh, 2004, Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy., Diabetes source
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Study design and conductnone givenFor mouse experiments, all data were reported as mean±s.d. and Student's t tests (unpaired, two-tailed) were used to compare significance between the two groups.
“For experiments involving mice, all data were reported as mean±s.d. Student’s t tests (unpaired, two-tailed) were used to compare the significance between the two groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenFor the analyses of blood lipids, individuals taking lipid-lowering drugs were excluded.
“For the analyses of blood lipids, those who were taking lipid-lowering drugs were excluded.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataManhattan plots were generated from exome-wide SNPs, with known BP GWAS ± 500 Kb regions marked as positive controls and to filter newly discovered loci.
“Manhattan plots were generated from exome-wide SNPs, with marked of known BP GWAS ± 500 Kb region as positive controls and to filter the newly discovered loci.”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Study design and conductown dataPhenotypes were adjusted for age, age2, BMI, and sex before running the mixed linear model on residuals and exome-wide SNPs.
“As described above, we adjusted for age, age2, BMI, and sex for our phenotypes first and run mixed linear model based on the residuals and the exome-wide SNPs.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenQuantile-quantile plots were depicted for SNPs in different minor allele frequency groups.
“Quantile-quantile plots were depicted for SNPs in different minor allele frequency groups.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The human CCDC93 rs33975708 variant leads to genetic deficiency of CCDC93.
“as the variant in humans was predicted to lead to genetic deficiency of this gene.”
The paper relies on this without support.
The Ccdc93+/- heterozygous mouse is a valid model of the human CCDC93 rs33975708 loss-of-function state.
“we undertook studies of a genetic mouse model of CCDC93 loss, as the variant in humans was predicted to lead to genetic deficiency of this gene.”
The paper relies on this without support.
Mouse SBP findings can confirm the direction of the human genetic effect on SBP.
“SBP elevation was observed in Ccdc93+/- mice as compared to their Ccdc93+/+ littermate controls, confirming the direction of the discovered human genetic effect.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Long-term averaged cSBP has a smaller, not stronger, effect estimate
MinorThe long-term averaged estimate is 24.63, below the initial discovery estimate of 29.31. Its reported P-value is lower, but its effect estimate is not stronger in magnitude.
“LTA-cSBP was associated with rs33975708, with a stronger effect estimate and lower p-value (β = 24.63, SE = 6.62, P = 9.95×10−8) as compared to the initial discovered association result (S2 Table).”
“β = 29.31; SE = 5.53; P = 1.23×10−7”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
GENCODE reference annotation for the human and mouse genomes
Frankish, A., Diekhans, M., Ferreira, A.-M., Johnson, R., Jungreis, I., Loveland, J. E., Mudge, J. M., Sisu, C., Wright, J. C., Armstrong, J. C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky955 · Cited by 2,983
Self-citationVariance component model to account for sample structure in genome-wide association studies
Kang, H. M., Sul, J. H., Service, S. K., Zaitlen, N. A., Kong, S.-Y., Freimer, N. B., Sabatti, C., & Eskin, E. (2010) · Nature Genetics · doi:10.1038/ng.548 · Cited by 2,817
Gakidou, E., Afshin, A., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32366-8 · Cited by 2,406
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., et al. (2017) · JAMA · doi:10.1001/jama.2016.19043 · Cited by 2,381 · cited 1×
“Elevated blood pressure (BP) is the leading modifiable risk factor for cardiovascular disease and stroke [1,2].”
BackgroundHeart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., BORER, J. S., & Boudoulas, H. K. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,952
The CAFE Investigators, CAFE Steering Committee and Writing Committee, Williams, B., Lacy, P. S., Thom, S. M., Cruickshank, K., Stanton, A., Collier, D., Hughes, A. D., Thurston, H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.595496 · Cited by 1,645
Program, T. M. V., Evangelou, E., Warren, H. R., Mosen-Ansorena, D., Mifsud, B., Pazoki, R., Gao, H., Ntritsos, G., Dimou, N., Cabrera, C. P., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0205-x · Cited by 1,381
Genome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215
Roman, M. J., Devereux, R. B., Kizer, J. R., Lee, E. T., Galloway, J. M., Ali, T., Umans, J. G., & Howard, B. V. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089078 · Cited by 1,080
Grygiel-Górniak, B. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-17 · Cited by 1,079
Role of BNIP3 and NIX in cell death, autophagy, and mitophagy
Zhang, J., & Ney, P. A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.16 · Cited by 1,021
Self-citationCross talk between mitochondria and NADPH oxidases
Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783
Genetics of 35 blood and urine biomarkers in the UK Biobank
Sinnott-Armstrong, N., Tanigawa, Y., Amar, D., Mars, N., Benner, C., Aguirre, M., Venkataraman, G. R., Wainberg, M., Ollila, H. M., Kiiskinen, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00757-z · Cited by 744
Genetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program
Global Lipids Genetics Consortium, Klarin, D., Myocardial Infarction Genetics (MIGen) Consortium, The Geisinger-Regeneron DiscovEHR Collaboration, Program, T. V. M. V., Damrauer, S. M., Cho, K., Sun, Y. V., Teslovich, T. M., Honerlaw, J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0222-9 · Cited by 625
Self-citationMitochondrial abnormalities in Alzheimer brain: Mechanistic implications
Bubber, P., Haroutunian, V., Fisch, G., Blass, J. P., & Gibson, G. E. (2005) · Annals of Neurology · doi:10.1002/ana.20474 · Cited by 622
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
Singh, S., Brocker, C., Koppaka, V., Chen, Y., Jackson, B. C., Matsumoto, A., Thompson, D. C., & Vasiliou, V. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.010 · Cited by 601
Self-citationWarren, H. R., Εvangelou, Ε., Cabrera, C. P., Gao, H., Ren, M., Mifsud, B., Ntalla, I., Surendran, P., Liu, C., Cook, J. P., et al. (2017) · Nature Genetics · doi:10.1038/ng.3768 · Cited by 559
Ding, W.-X., Ni, H.-M., Li, M., Liao, Y., Chen, X., Stolz, D. B., Dorn, G. W., & Yin, X.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119537 · Cited by 551
Role of Pulse Pressure Amplification in Arterial Hypertension
Avolio, A. P., Bortel, L. M. V., Boutouyrie, P., Cockcroft, J. R., McEniery, C. M., Protogerou, A. D., Roman, M. J., Safar, M. E., Segers, P., & Smulyan, H. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134379 · Cited by 530
Ge, P., Dawson, V. L., & Dawson, T. M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00367-7 · Cited by 496
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals
Understanding Society Scientific Group, Giri, A., International Consortium for Blood Pressure, Blood Pressure-International Consortium of Exome Chip Studies, Program, M. V., Hellwege, J. N., Keaton, J. M., Park, J., Qiu, C., Warren, H. R., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0303-9 · Cited by 459
Ehret, G., Ferreira, T. C., Chasman, D. I., Jackson, A., Schmidt, E. M., Johnson, T., Þorleifsson, G., Luan, J., Donnelly, L. A., Kanoni, S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3667 · Cited by 417
Pini, R., Cavallini, M. C., Palmieri, V., Marchionni, N., Di Bari, M., Devereux, R. B., Masotti, G., & Roman, M. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.031 · Cited by 386
Wang, K.-L., Cheng, H.-M., Chuang, S.-Y., Spurgeon, H. A., Ting, C.-T., Lakatta, E. G., Yin, F. C., Chou, P., & Chen, C.-H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283220ea4 · Cited by 362
Dikalov, S. I., & Nazarewicz, R. R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4604 · Cited by 356
Lee, C. H., Cook, S., Lee, J. S., & Han, B. (2016) · Genomics & Informatics · doi:10.5808/gi.2016.14.4.173 · Cited by 308
Kopan, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011213 · Cited by 294
Kollias, A., Lagou, S., Zeniodi, M. E., Boubouchairopoulou, N., & Stergiou, G. S. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06066 · Cited by 287
Xanthine Oxidoreductase‐Derived Reactive Species: Physiological and Pathological Effects
Battelli, M. G., Polito, L., Bortolotti, M., & Bolognesi, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3527579 · Cited by 281
Bénétos, A., Thomas, F., Joly, L., Blacher, J., Pannier, B., Labat, C., Salvi, P., Smulyan, H., & Safar, M. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.061 · Cited by 228
Ghosh, S. M., Kapil, V., Fuentes-Calvo, I., Bubb, K. J., Pearl, V., Milsom, A. B., Khambata, R., Maleki-Toyserkani, S., Yousuf, M., Benjamin, N., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00933 · Cited by 218
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Tesson, C., Nawara, M., Salih, M. A. M., Rossignol, R., Zaki, M. S., Al Balwi, M., Schule, R., Mignot, C., Obre, E., Bouhouche, A., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.11.001 · Cited by 203
Amplification of the Pressure Pulse in the Upper Limb in Healthy, Middle-Aged Men and Women
Segers, P., Mahieu, D., Kips, J. G., Rietzschel, E. R., Buyzere, M. D., Bacquer, D. D., Bekaert, S., Backer, G. D., Gillebert, T. C., Verdonck, P., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133009 · Cited by 191
Acyl-CoA Dehydrogenase 9 Is Required for the Biogenesis of Oxidative Phosphorylation Complex I
Nouws, J., Nijtmans, L., Houten, S. M., van den Brand, M., Huynen, M., Venselaar, H., Hoefs, S., Gloerich, J., Kronick, J., Hutchin, T., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.002 · Cited by 190
Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
Battelli, M. G., Polito, L., & Bolognesi, A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.006 · Cited by 179
Free Fatty Acid Levels Modulate Microvascular Function
de Jongh, R. T., Serné, E. H., IJzerman, R. G., de Vries, G., & Stehouwer, C. D. A. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2873 · Cited by 179
Atlante, A., Calissano, P., Bobba, A., Azzariti, A., Marra, E., & Passarella, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002361200 · Cited by 178
Role of Mitochondrial Dysfunction in Hypertension and Obesity
Lahera, V., de las Heras, N., López-Farré, A., Manucha, W., & Ferder, L. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0710-9 · Cited by 176
Sung, Y. J., Winkler, T. W., Fuentes, L. D. L., Bentley, A. R., Brown, M. R., Kraja, A. T., Schwander, K., Ντάλλα, Ι., Guo, X., Franceschini, N., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.015 · Cited by 162
Teusink, B., Voshol, P. J., Dahlmans, V. E. H., Rensen, P. C. N., Pijl, H., Romijn, J. A., & Havekes, L. M. (2003) · Diabetes · doi:10.2337/diabetes.52.3.614 · Cited by 152
The in vivo endothelial cell translatome is highly heterogeneous across vascular beds
Cleuren, A. C. A., van der Ent, M. A., Jiang, H., Hunker, K. L., Yee, A., Siemieniak, D. R., Molema, G., Aird, W. C., Ganesh, S. K., & Ginsburg, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912409116 · Cited by 152
Self-citationCheng, H.-M., Chuang, S.-Y., Sung, S.-H., Yu, W.-C., Pearson, A., Lakatta, E. G., Pan, W.-H., & Chen, C.-H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.029 · Cited by 148
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
Interethnic analyses of blood pressure loci in populations of East Asian and European descent
Takeuchi, F., Akiyama, M., Matoba, N., Katsuya, T., Nakatochi, M., Tabara, Y., Narita, A., Saw, W., Moon, S., Spracklen, C. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07345-0 · Cited by 122
Self-citationTang, C. S.-M., Zhang, H., Cheung, C. Y. Y., Xu, M., Ho, J. C.-Y., Zhou, W., Cherny, S. S., Zhang, Y., Holmen, O. L., Au, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms10206 · Cited by 111
Self-citationTeissier, E., Nohara, A., Chinetti, G., Paumelle, R., Cariou, B., Fruchart, J.-C., Brandes, R. P., Shah, A., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000150594.95988.45 · Cited by 110
Carlsson, M., Wessman, Y., Almgren, P., & Groop, L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1588 · Cited by 95
Sarafidis, P. A., & Bakris, G. L. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002103 · Cited by 94
Heritability of Central Systolic Pressure Augmentation: A Twin Study
Snieder, H., Hayward, C. S., Perks, U., Kelly, R. P., Kelly, P. J., & Spector, T. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.574 · Cited by 86
Fan, F., Qi, L., Jia, J., Xu, X., Liu, Y., Yang, Y., Qin, X., Li, J., Li, H., Zhang, Y., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.07019 · Cited by 84
Self-citationCentral blood pressure and hypertension: role in cardiovascular risk assessment
Safar, M. E., & Jankowski, P. (2009) · Clinical Science · doi:10.1042/cs20080072 · Cited by 75
Role of S-Palmitoylation by ZDHHC13 in Mitochondrial function and Metabolism in Liver
Shen, L.-F., Chen, Y.-J., Liu, K.-M., Haddad, A. N. S., Song, I.-W., Roan, H.-Y., Chen, L.-Y., Yen, J. J. Y., Chen, Y.-J., Wu, J.-Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02159-4 · Cited by 74
Self-citationEndosomal sorting of Notch receptors through COMMD9-dependent pathways modulates Notch signaling
Li, H., Koo, Y., Mao, X., Sifuentes-Dominguez, L., Morris, L. L., Jia, D., Miyata, N., Faulkner, R. A., van Deursen, J. M., Vooijs, M., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201505108 · Cited by 73
Ganesh, S. K., Chasman, D. I., Larson, M. G., Guo, X., Verwoert, G., Bis, J. C., Gu, X., Smith, A. V., Yang, M.-L., Zhang, Y., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.06.002 · Cited by 71
Self-citationKelly, T. N., Takeuchi, F., Tabara, Y., Edwards, T. L., Kim, Y. J., Chen, P., Li, H., Wu, Y., Yang, C.-F., Zhang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01148 · Cited by 66
Self-citationOver 1000 genetic loci influencing blood pressure with multiple systems and tissues implicated
Cabrera, C., Ng, F. L., Nicholls, H., Gupta, A. K., Barnes, M. R., Munroe, P. B., & Caulfield, M. J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz197 · Cited by 63
Tyrrell, D. J., Blin, M. G., Song, J., Wood, S. C., & Goldstein, D. R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017820 · Cited by 52
Kumar, N., Zuo, Y., Yalavarthi, S., Hunker, K. L., Knight, J. S., Kanthi, Y. M., Andrea, T., & Ganesh, S. K. (2020) · Viruses · doi:10.3390/v13112209 · Cited by 51
Self-citationCecelja, M., Keehn, L., Ye, L., Spector, T. D., Hughes, A. D., & Chowienczyk, P. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa238 · Cited by 48
Kwon, D.-N., Park, W.-J., Choi, Y.-J., Gurunathan, S., & Kim, J.-H. (2015) · Aging · doi:10.18632/aging.100800 · Cited by 45
Cheng, H., Chuang, S., Wang, T., Kario, K., Buranakitjaroen, P., Chia, Y. C., Divinagracia, R. A., Hoshide, S., Minh, H. V., Nailes, J. M., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13758 · Cited by 45
Self-citationHeritability of blood pressure traits in diverse populations: a systematic review and meta-analysis
Kolifarhood, G., Daneshpour, M., Hadaegh, F., Sabour, S., Mozafar Saadati, H., Akbar Haghdoust, A., Akbarzadeh, M., Sedaghati-Khayat, B., & Khosravi, N. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0253-4 · Cited by 42
Zhan, C., Shi, M., Yang, Y., Pang, H., Fei, S., Bai, L., Liu, B., Tu, J., Huo, Y., Ning, X., et al. (2016) · Scientific Reports · doi:10.1038/srep23870 · Cited by 41
Self-citationMcGaughey, T. J., Fletcher, E. A., & Shah, S. A. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpv134 · Cited by 40
Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease
Rahman, M., Hsu, J. Y., Desai, N. B., Hsu, C., Anderson, A. H., Appel, L. J., Chen, J., Cohen, D. L., Drawz, P. E., He, J., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08620817 · Cited by 33
Zhang, Y., Long, J., Lü, W., Shu, X., Cai, Q., Zheng, Y. F., Li, C., Li, B., Gao, Y., & Zheng, W. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1043 · Cited by 29
Self-citationThymosin β4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II–Induced Hypertension
Kumar, N., Liao, T.-D., Romero, C. A., Maheshwari, M., Peterson, E. L., & Carretero, O. A. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10952 · Cited by 26
Self-citationRimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24
Dong, Y., Jiang, L., Wang, X., Chen, Z., Zhang, L., Zhang, Z., Zheng, C., Kang, Y., Wang, Z., Cao, H., et al. (2020) · The Journal of Clinical Hypertension · doi:10.1111/jch.13838 · Cited by 22
Self-citationLamarche, F., Agharazii, M., Nadeau-Fredette, A.-C., Madore, F., & Goupil, R. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10476 · Cited by 19
Novel exomic rare variants associated with venous thrombosis
Deguchi, H., Shukla, M., Hayat, M., Torkamani, A., Elias, D. J., & Griffin, J. H. (2020) · British Journal of Haematology · doi:10.1111/bjh.16613 · Cited by 19
Sun, P., Yang, Y., Cheng, G., Fan, F., Qi, L., Gao, L., Han, X., Jia, J., Huo, Y., & Zhang, Y. (2018) · Hypertension Research · doi:10.1038/s41440-018-0175-5 · Cited by 17
Self-citationGeneration of Transgenic Mice by Pronuclear Microinjection
Becker, K., & Jerchow, B. (2011) · Springer Protocols Handbooks · doi:10.1007/978-3-642-20792-1_6 · Cited by 17
Association between ankle blood pressure and central arterial wave reflection
Tarumi, T., Sugawara, J., & Tanaka, H. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.100 · Cited by 16
Generation of Transgenic Mice by Pronuclear Microinjection
Becker, K., & Jerchow, B. (2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-3-662-45763-4_6 · Cited by 16
Patel, R. S., Morris, A. A., Ahmed, Y., Kavtaradze, N., Sher, S., Su, S., Zafari, A. M., Din-Dzietham, R., Waddy, S. P., Vaccarino, V., et al. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.41 · Cited by 14
Wang, S., Zhou, Z., Fan, F., Qi, L., Jia, J., Sun, P., Jiang, Y., Kou, M., Chen, D., Zhang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21023-7 · Cited by 13
Self-citationStevenson, M. D., Vendrov, A. E., Yang, X., Chen, Y., Navarro, H. A., Moss, N., Runge, M. S., Arendshorst, W. J., & Madamanchi, N. R. (2023) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00236.2022 · Cited by 8
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
GWAS for Defining the Pathogenesis of Hypertension: Have They Delivered?
Alexander, M. R., Edwards, T. L., & Harrison, D. G. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.23451 · Cited by 12
Metadata
- Authors
- Kumar, N., Yang, M.-L., Sun, P., Hunker, K. L., Li, J., Jia, J., Fan, F., Wang, J., Ning, X., Gao, W., Xu, M., Zhang, J., Chang, L., Chen, Y. E., Huo, Y., Zhang, Y., & Ganesh, S. K.
- Affiliations
- University of Michigan (US)
- Tianjin Medical University General Hospital (CN)
- Peking University First Hospital (CN)
- Peking University Third Hospital (CN)
- Corresponding author
- Zhang, Yan
- Ganesh, Santhi K.
- ORCID
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2024-09-09
- Volume
- 20
- Issue
- 9
- Pages
- e1011151
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC11421807
- OpenAlex
- W4402353947
- Cited by
- 1
- References
- 86
- Citations by year
- 2025: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Update notices
- new_version (2024-09-24)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- UM-PUHSC Joint Institute (BMU20110177 and BMU20160530)
- National High Level Hospital Clinical Research Funding (2022CR71)
- National Key Research and Development Program of China (2021YFC2500500 and 2021YFC2500503)
- Key Laboratory of Molecular Cardiovascular Sciences
- National Health Commission Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides
- National Institutes of Health (R01HL139672, R01HL122684, R01HL086694, R35HL161016)
- University of Michigan A. Alfred Taubman Institute
- National Center for Advancing Translational Sciences (UL1TR002240)
- University of Michigan Medical School Office of Research
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- central systolic blood pressure, arterial relaxation, mitochondrial dysfunction, mitochondrial metabolism, fatty acid metabolism, free fatty acids, acetylcholine-induced relaxation, phenylephrine-induced contraction, aortic smooth muscle, genetic association, Han Chinese, blood pressure regulation, CRISPR/Cas9 genome editing, wire myography, transcriptome
- MeSH terms
- East Asian People, Animals, Blood Pressure, Female, Humans, Hypertension, Male, Middle Aged, Mitochondria, Vasodilation, Polymorphism, Single Nucleotide, Vesicular Transport Proteins, Mice, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review